Medtronic launches atrial fibrillation trial; Investor sues NuVasive for unpaid milestone money;

 @FierceMedDev: FDA plans to clamp down on all-metal hips. Article | Follow @FierceMedDev

 @DamianFierce: Big M&A morning: Stryker's ($SYK) spending $764 million on Chinese orthopedics company Trauson. Release | Follow @DamianFierce

> Medtronic ($MDT) has launched a trial to see whether its Reveal Insertable Cardiac Monitor can identify and predict atrial fibrillation in patients at high risk for the disease. More

> Gore is launching a new version of its Q50 Plus Stent Graft Balloon Catheter, a device made to work with aortic stent grafts and treat abdominal aortic aneurysms. Release

> Devicemaker Sanovas has filed for FDA clearance for its Vas Zeppelin Smart Catheter, designed to treat chronic pulmonary diseases and lung cancer. News

> Back in 2009, when NuVasive ($NUVA) acquired Cervitech, it agreed to pay out milestones when the company's device got FDA approval. Now, a Cervitech investor is suing, saying he never got his cut. Story

> Drug delivery specialist pSivida ($PSDV) is expanding the use of its back-of-the-eye delivery device, as Iluvien, a drug that uses the tech, got market approval in Spain. Item

> Covidien ($COV) is partnering with the NFL Players Association and the Living Heart Foundation to launch the HOPE Program, designed to promote healthy lifestyles for former NFL athletes. Release

Biotech News

 @FierceBiotech: Popular yesterday : Buzz: $AZN reorg inspires fresh rumors of $SHPG bid. Report | Follow @FierceBiotech

@JohnCFierce: Columnist gushes over Inovio's Kim, a tireless promoter whose stock is trading at .67 and whose flu vax is in PhI. Column | Follow @JohnCFierce

@RyanMFierce: $EXEL's plethora of partnerships bearing fruit as Genentech moves melanoma drug from EXEL into PhIII. More | Follow @RyanMFierce

> FDA green-lights a flu vaccine made with new technology. Story

> Genentech launches PhIII for melanoma combo with GSK in hot pursuit. Article

> AstraZeneca shakeup pushes research chief to top of restructured MedImmune. News

Pharma News

@FiercePharma: Bond market pants for Pfizer vet unit's debut offering: Zoetis sets up $3.65B in debt amid final prep for IPO. More | Follow @FiercePharma

 @AlisonBFierce: FierceVaccines brings you the major FDA vaccine approvals from 2012. Special Report | Follow @AlisonBFierce

> Aranesp flunks heart-failure trial, raising new questions about use. News

> MedImmune unit split 3 ways in AstraZeneca shake-up. More

> AARP, AFL-CIO and prominent docs to White House: Get us the sunshine rules, stat. Story

Vaccines News

> IOM confirms safety of childhood vaccine schedule. Report

> CDC: Flu hits epidemic level in U.S. Item

> Protein Sciences nabs Flublok approval. News

> Vaccine stakes upped as dengue dubbed fastest-spreading tropical disease. Article

> Flu vaccine, Tamiflu shortage as influenza sweeps U.S. Story

Pharma Manufacturing News

 @EricPFierce: Amgen to build $200 million monoclonal antibody plant in Singapore. Novartis building there too. More | Follow @EricPFierce

> Wisconsin report adds to drug take-back funding debate. Item

> China ups bounty for tips on counterfeiters to $48,500. Report

> Japan's Mitsui ups stake in India API maker Arch. Story

> FDA spells out user fees for generic drugs. Article

> J&J consent decree cost felt at the pharmacy. More

Suggested Articles

Sherlock Biosciences teamed up with Cepheid to help develop its CRISPR-based molecular diagnostic tech in oncology, infections and the coronavirus.

The spine surgery company ATEC has moved to acquire Paris-based EOS imaging, makers of FDA-cleared scanners and 3D orthopedic planning software.

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.